The immunomodulatory role of CALRETICULIN in acute myeloid leukemia
Acute myeloid leukemia (AML) is one of the most common and deadliest form of blood cancer in adults, accounting for over 80% of acute leukemic diagnoses. Despite the introduction of new targeted therapies, survival rate remains low in adults, and new therapeutic approaches are needed. In a previous CRISPR screen performed by the Järås group, CALRETICULIN was identified as a regulator of human leuc
